Medical Procedure Sidelines Jerome Randle

Oct. 29, 2007

BERKELEY - University of California sophomore point guard Jerome Randle, who was challenging for a starting position this fall, underwent a biopsy on his kidney Monday afternoon.

A recent routine blood test incidentally picked up minor abnormalities, and doctors concluded that he needed today's diagnostic procedure. Results of the biopsy, which will not be available for several days, will determine when Randle will be able to be back on the court.

'We're hopeful that the results of the procedure will help provide Jerome with a long-term solution and that he will be able to return following his recovering period,' head coach Ben Braun said.

The normal recovery period for a biopsy is 3-4 weeks.

Last season, Randle played in all 33 games for the Bears, starting once at Washington, and averaged 6.5 ppg and 2.8 apg. He led the team in free throw shooting (81.4 percent) and scored a career-high 19 points vs. Stanford in a Feb. 3 home game.

Cal will suit up just one scholarship point guard, sophomore Nikola Knezevic, until Randle is back in the lineup. Walk-ons Nican Robinson and David Liss are expected to serve as reserves.

Randle becomes the third Golden Bear to miss time early in the year. Freshman forward Omondi Amoke continues to rehabilitate from surgery for a vascular abnormality in his calf, while junior forward Theo Robertson may be out until late December as he recuperates from April hip surgery.

Over the past year and a half, seven Cal players have undergone surgery, including Knezevic, center Jordan Wilkes and center DeVon Hardin, who missed most or all of last season.

Now on Pac-12 Network
4:30 AM PT

Airing on:

  • Pac-12 Network
Get Pac-12 Networks
Pac-12 Networks Channel Finder